Skip to search formSkip to main contentSkip to account menu

RO5503781

Known as: RO-5503781 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Idasanutlin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Combination of ro5503781 and capecitabine for cancer therapy
The present invention is a pharmaceutical product, said product comprising a second composition comprising the following a) for… 
2014
2014
Combination of ro5503781, capecitabine and oxaliplantin for cancer therapy
Herein, the first component comprising a pharmaceutical composition comprising a compound, or a pharmaceutically acceptable salt… 
2014
2014
For the treatment of cancer, a combination of ro5503781 and capecitabine
For the treatment of simultaneous or sequential cancer, a) Formula (A) a first component comprising a compound of; pharmaceutical… 
2014
2014
For the treatment of cancer, ro5503781, the combination of capecitabine and oxaliplatin
This application, a) as a first component, a compound (pharmaceutical composition comprising as an active ingredient a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)